2023 CiteScore: 0.7
pISSN: 0044-6025
eISSN: 1735-9694
Editor-in-Chief:
Ahmadreza Dehpour, PharmD, PhD
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
Vol 37, No 4 (1999)
We have Investigated the preventive effects of oral administration of isolated E.coli ghttam'tc acid decarboxylase (GAD) in animal models. Based on our results, the blood glucose levels were reduced by oral administration of GAD to rats 14 days before intraperitoneal injections of streptozocin (40 mg/kg on five consecutive days). On the other hand, oral administration of GAD to rats before streptozocin treatment significantly (P< 0.05) reduced the levels of GAD - specific antibodies and improved the in vitro proliferative responses of splenocytes to Con A- These data demonstrate tliat oral GAD administration probably generates active cellular meciianisms tliat suppress the disease and raise the possibility of using E.coli GAD as a new means for the prevention of autoimmune diabetes.
2023 CiteScore: 0.7
pISSN: 0044-6025
eISSN: 1735-9694
Editor-in-Chief:
Ahmadreza Dehpour, PharmD, PhD
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |